European Pharmaceutical Review

MARCH 18, 2024

Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute explained. and Joan A. He noted that this means the treatment dose needs to be increased or administered more often.

Food and Drug Administration 91

Food and Drug Administration Medicine Physicians Food 91

PM360

SEPTEMBER 7, 2023

A similar number of respondents (64%) expressed disappointment with their interaction with physicians, wishing that healthcare providers took more time to understand them. The New England Journal of Medicine runs a weekly diagnostic challenge tasking physicians with correctly identifying a thorny case.

Patients 111

Patients Physicians Healthcare Healthcare 111

Clarify Health

JANUARY 29, 2024

Poor care transition management can lead to fragmented healthcare delivery, often leading to increased patient readmissions, compromised health outcomes, and elevated costs. By actively managing transitions, hospitals can reduce the likelihood of adverse events, improve patient safety, and enhance overall healthcare quality.

Management 52

Management Healthcare Provider Safety Healthcare 52

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

Clarivate

MAY 1, 2024

However, the high cost associated with the drugs, along with spotty reimbursement and side effects, could prompt some patients to reconsider a surgical approach whose safety and efficacy are well understood. Device-based treatments for comorbidities associated with obesity will also see an impact.

Side effects 52

Side effects Physicians Medical Patients 52

Pharmaceutical Technology

MAY 18, 2023

This move shows the FDA’s determination to accept the NDA as a class 2 review that leads to a six-month evaluation period starting from the resubmission date. Ardelyx’s resubmitted NDA is based on a comprehensive development programme that enrolled over 1,200 patients in three Phase III trials assessing the safety and efficacy of XPHOZAH.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Food 52

World of DTC Marketing

AUGUST 12, 2022

He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million. And yet, he said, regulatory changes rarely choked out investment in new drugs.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

Pharmaceutical Technology

AUGUST 2, 2022

It can also lead to more personalised treatment approaches and lay a stronger foundation for value-based care. According to the same report, physicians from the UK, Spain and China were the most positive about the ability of EHRs to increase patients’ quality of care.

Electronics 64

Electronics Physicians Healthcare Healthcare 64

Legacy MEDSearch

FEBRUARY 28, 2023

In addition, pooled analysis results from the combined primary efficacy endpoint and safety data from RADIANCE SOLO, RADIANCE TRIO, and RADIANCE II were concurrently published in JAMA Cardiology. The study also achieved its primary safety composite outcome with no major adverse events observed. mmHg, compared to a reduction of -1.8

Networking 98

Networking Medical Physicians Safety 98

European Pharmaceutical Review

SEPTEMBER 15, 2022

The long-term data analyses of the Phase III KEEPsAKE 1 and 2 trials also revealed no new observed safety signals through 100 weeks. ” Skyrizi was generally well-tolerated and no new safety signals were noted in both KEEPsAKE 1 and 2 at 100 weeks of treatment. . Serious treatment-emergent adverse events (TEAEs) occurred at 7.6

Safety 70

Safety Physicians Patients Consulting 70

Pharmaceutical Technology

MARCH 23, 2023

The presentation highlighted the efficacy and safety of PRA023, an anti-TL1A asset, in a small sample size (N=50) of CD patients. However, the widespread adoption of such trials is unlikely, as they increase the probability the investigative therapy will fail to show significant efficacy and/or improved safety.

Safety 52

Safety Healthcare Provider Physicians Marketing 52

PM360

DECEMBER 14, 2023

A New Online Destination for HCPs HealthCentral Corporation , operator of leading digital platforms that serve patients living with chronic illness, their care partners, and health professionals, has announced the newest addition to its suite of HCP support sites: MedCentral.

Physicians 52

Physicians Pharma Medical Patients 52

pharmaphorum

NOVEMBER 30, 2022

X4 Pharmaceuticals has announced positive top-line results from a Phase 3 study of its lead investigational therapy, mavorixafor, in people with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome. Dubbed 4WHIM, the trial was initially designed to enrol 18-28 patients.

Pharmaceutical 62

Pharmaceutical Safety Physicians Patients 62

Pharma Leaders

MAY 18, 2023

The regulatory agency has determined that the NDA is a class 2 review , which leads to a six-month review period from the date of resubmission. It has set a user fee goal date of 17 October this year. The biopharmaceutical company expects XPHOZAH to be commercially available in Q4 2023 after an approval from the regulatory body.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

Legacy MEDSearch

SEPTEMBER 5, 2023

software intended to assist physicians in planning liver ablation procedures, and confirming ablation zones, with the goal of increasing treatment precision. employs advanced computation and image registration to assist physicians in crucial steps of planning and assessing the ablation coverage of liver tumor. Techsomed Ltd.,

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

LEVO Health

FEBRUARY 1, 2024

Unlike traditional methods, this approach allows for messaging that resonates on a personal level , leading to improved engagement and outcomes. The campaign could segment HCP audiences into various groups, such as endocrinologists, primary care physicians, and diabetes specialists.

Healthcare 52

Healthcare Healthcare Patients Marketing 52

Pharma Marketing Network

JULY 26, 2023

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

Referral MD

APRIL 19, 2024

The lack of effective tracking mechanisms makes it difficult for coordinators to monitor referral status, potentially leading to missed patient appointments and delayed treatments. Miscommunication or system errors can lead to referrals not reaching their intended destination, frustrating patients and providers.

Healthcare 40

Healthcare Healthcare Patients Management 40

Pharmaceutical Technology

MAY 18, 2023

enGene CEO Jason Hanson said: “Our mission at enGene is to broaden the reach of gene therapy by creating safe, locally deliverable, non-viral therapies while freeing physicians from the onerous handling procedures typically required by viral-based gene therapy products. The proposed transaction will conclude in the second half of 2023.

Physicians 52

Physicians Leads Safety Healthcare 52

pharmaphorum

OCTOBER 12, 2022

Blaine Martin, Digital Health, New Product Planning and Portfolio Expansion, Franchise Lead, Fertility, Merck. Steve Hoare, Quality, Regulatory Science & Safety Policy Director, The Association of the British Pharmaceutical Industry (ABPI). Clemens Gunther, Director, Senior Expert Nonclinical Safety, Bayer.

Engineering 52

Engineering Safety Consulting Medical 52

Clarify Health

MARCH 1, 2023

Placing clinicians at financial risk for controlling health costs and improving quality without equipping them with the tools to do so leads to frustration and disillusionment. Physicians dislike being outliers and adjust their practice patterns to conform when provided with a relative social ranking. million on orthopedic MS-DRGs.[1]

Physicians 52

Physicians Prescription Medicine Healthcare 52

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

PM360

APRIL 7, 2023

Furthermore, many people underestimate their healthcare costs and do not save enough for annual expenditures, often leading to delays in treatment that can be detrimental to the patient. CMS factored in the efficacy of the device as well as its safety beyond the use of opioids. One in three (33%) U.S. While 20% of U.S. In the U.S.,

Healthcare 52

Healthcare Healthcare Insurance Physicians 52

Pharmaceutical Technology

JANUARY 10, 2023

The erosion of Januvia is due to patent expiry in that had been expected in 2022 and physicians’ preference for sodium-glucose linked transporter-2 inhibitor (SGLT-2I) therapies such as Farxiga (dapagliflozin) and Jardiance (empagliflozin) due to their ability to improve glycemic control and address cardiorenal comorbidities.

Marketing 52

Marketing Physicians Leads Competition 52

Legacy MEDSearch

JANUARY 13, 2023

The IDE Study is being conducted to determine the safety and effectiveness of the HIT Reverse HRS in Primary Total Hip Arthroplasty (THA). Safety will be assessed through the collection of device-related adverse events and patient quality of life metrics. About Hip Innovation Technology, LLC.

FDA 98

FDA Safety Recruitment Patients 98

Pharmaceutical Technology

JANUARY 23, 2023

In recent years, with the advent of biologics and novel therapeutic targets such as anti-TNF, anti-interleukin, and anti-integrin, there has been a steady increase in the number of agents approved to treat inflammatory bowel diseases (IBD), which has provided physicians with an increasing number of options to treat Crohn’s disease (CD).

Medical 59

Medical Ethics Specialization Physicians 59

PM360

SEPTEMBER 15, 2022

based physicians reveals that a majority are concerned and confused about what constitutes a life-threatening emergency that would make an abortion procedure legal in those 11 states where it has been banned. Doctor Docs: Doctors Left Concerned After Roe v. Wade Overturn. A recent Sermo study of 240 U.S.-based Or must it be 100%?”.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

European Pharmaceutical Review

JULY 13, 2023

In many European countries physicians can now prescribe medical cannabis for an array of chronic health conditions, including chronic pain, mental health disorders and neurological conditions. This could lead to significant research waste. References Attwood D, Curley A, Keenan E, Murphy S. The European Cannabis Report (7th Ed.).

Medical 87

Medical Food and Drug Administration Pharmacology Medicine 87

Legacy MEDSearch

JULY 21, 2023

“We are addressing the observations by so many physicians that there is a vast unmet need for a better way to definitively treat this female population.” This first-in-female procedure was approved by the National Agency for the Safety of Medicines and Health Products (or ANSM, the French equivalent to the U.S.

Food and Drug Administration 52

Food and Drug Administration Patients Safety Recruitment 52

Legacy MEDSearch

JULY 27, 2022

Rapid Medical , a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. The ability to tailor each procedure can provide new safety levels for higher-risk thrombectomies.

Medical 52

Medical FDA Recruitment Physicians 52

Pharma Marketing Network

JULY 19, 2023

For example, Pfizer, a leading pharmaceutical company, has a long history of sponsoring research into new drugs and treatments. For example, Merck, another leading pharmaceutical company, has a website that provides information about a variety of health conditions.

Pharmaceutical 98

Pharmaceutical Healthcare Healthcare Education 98

pharmaphorum

OCTOBER 18, 2022

It will create a Nasdaq-listed biopharmaceutical company under the name “Oculis Holding SA”, placing Oculis in position to become a leading global ophthalmic biopharma, with product candidates to address areas of significant medical needs affecting a growing number of patient populations.

Biopharma 57

Biopharma Management Specialization Physicians 57

Clarivate

OCTOBER 25, 2023

Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e., How the IRA could affect treatment choice While price negotiations are intended to lower Medicare costs, they also present a challenge to physician practice economics.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Legacy MEDSearch

JUNE 28, 2023

1 Early treatment of PWS during childhood leads to the best clinical response. 1 Early treatment of PWS during childhood leads to the best clinical response. 5 In fact, the Vbeam 595 nm PDL has been chosen by leading hospitals, 8 out of 10 of the top U.S. ”, states board-certified cosmetic dermatologist, Roy G. .”

Medical 52

Medical FDA Recruitment Side effects 52

European Pharmaceutical Review

MARCH 4, 2024

Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Dave Li, PhD Dave Li is a principal consultant and Clinical Research Physician with KCR. 2023; 13(3). Drug Deliv.

Food and Drug Administration 90

Food and Drug Administration Transportation FDA Medical 90

Pharmaceutical Technology

MARCH 24, 2023

Many experts have concerns that only a few Humira biosimilars will have access to the US market, while the rest will not be listed, thereby leading to lower savings than expected. Further, there remains scepticism on the efficacy and safety of biosimilars.

Competition 59

Competition Marketing FDA Physicians 59

Legacy MEDSearch

FEBRUARY 14, 2023

“We are pleased to lead this round as we see a significant opportunity to simplify and improve the safety and efficacy of TMVR procedures.” ” Mitral valve disease is the largest structural heart valve problem, impacting more than 6.6 million people, approximately four times more common than aortic stenosis.

Recruitment 52

Recruitment Management Medical Specialization 52